Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Precision and Ease-of-Use Characterize New Line of Microcentrifuges

By BiotechDaily International staff writers
Posted on 30 Jul 2013
Image: The Microfuge 20 micro-centrifuge (Photo courtesy of Beckman Coulter Life Sciences).
Image: The Microfuge 20 micro-centrifuge (Photo courtesy of Beckman Coulter Life Sciences).
A new line of microcentrifuges was designed to meet the specific requirements of a wide range of research applications while being efficient and easy to use.

The Beckman Coulter Life Sciences (Indianapolis, IN, USA) Microfuge 20 and 20R microcentrifuges are compact instruments that provide flexibility and reliable, precise performance whether in refrigerated (the Microfuge 20R) or nonrefrigerated (Microfuge 20) mode of operation. These microcentrifuges are intended for a wide range of biotech research applications including nucleic acid and protein preparation; pelleting, extractions, purifications, concentrations, phase separations and receptor binding; and rapid sedimentation of protein precipitates, particulates, and cell debris. An easy-to-use interface facilitates entry and recall of up to 10 user-defined programs.

Samples can be processed at speeds up to 15,000 rpm (20,627 x g) and the temperature in the Microfuge 20R can be adjusted over a range of -10 to +40 degrees Celsius. Fixed angle rotors are made of polypropylene or aluminum and offer capacities of 24 or 36 microcentrifuge tubes or four PCR tube strips.

“The Microfuge 20 series provides researchers with an accurate, reliable, and durable microcentrifuge,” said David Rolwing, centrifuge product manager at Beckman Coulter Life Sciences. “Strong performance and ergonomic features combine in these units to provide confidence and efficiency.”

Related Links:
Beckman Coulter Life Sciences




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This micrograph depicts the presence of aerobic Gram-negative Neisseria meningitidis diplococcal bacteria; magnification 1150x (Photo courtesy of the CDC - US Centers for Disease Control and Prevention).

Infection by Meningitis Bacteria Depends on Dimerization State of Certain Host Cell Proteins

A team of molecular microbiologists has untangled the complex three-way interaction between the non-integrin laminin receptor (LAMR1), galectin-3 (Gal-2), and the pathogenic bacterium Neisseria meningitidis.... Read more

Drug Discovery

view channel

Molecule in Green Tea Used as Carrier for Anticancer Proteins

A molecule that is a key ingredient in green tea can be employed as a carrier for anticancer proteins, forming a stable and effective therapeutic nanocomplex. This new discovery could help to construct better drug-delivery systems. Some cancer treatments depend on medication comprising the therapeutic drug and a carrier... Read more

Biochemistry

view channel

Discovery of Pain Receptor on T-cells Could Help Treat Autoimmune Disorders

Researchers have discovered that T-cells are activated by a pain receptor. The new findings revealed that the receptor helps control intestinal inflammation in mice and that its activity can be adjusted, providing a potential new target for treating certain autoimmune disorders, such as Crohn’s disease and possibly multiple... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.